Euromed (Dermapharm)
Spanish maker of Mediterranean botanical extracts made with water extraction, including pomegranate and olive.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Euromed S.A. is a Spanish botanical extract company founded in 1971 and headquartered in Mollet del Valles, Barcelona, Spain. Euromed has been owned by Dermapharm Holding SE (Germany) since 2019. The company specializes in standardized Mediterranean botanical extracts using proprietary Pure-Hydro Process (water-only extraction) technology. Key branded ingredients include Pomanox (pomegranate extract with 30% punicalagins, 15+ published studies including a 72-person RCT at Manchester Metropolitan University), Mediteanox (olive extract standardized for hydroxytyrosol per EFSA recommendations), and saw palmetto extracts. Euromed operates a US office in Bridgeville, Pennsylvania, and a saw palmetto procurement and drying facility in Central Florida.
Certifications
Certification verification in progress. International supplier records require regional database lookups (EudraGMDP, Health Canada NHP, FSSC public register, JHFA directory). See our methodology.
Capabilities
- PRODUCT TYPES
- Pomanox (Pomegranate Extract, 30% Punicalagins) · Mediteanox (Olive Extract, Hydroxytyrosol) · Saw Palmetto Extracts · Mediterranean Botanical Extracts · Standardized Herbal Extracts
- CAPABILITIES
- Botanical extracts or ingredients · Clinical research or study support · Sustainability programs
Sources
- Euromed Group Official Website(2026-04-02)
- Euromed Pomanox Clinical Research — Nutrients Editor's Choice(2026-04-02)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Owned by Dermapharm Holding SE (Germany) since 2019; not an independent Spanish company
- Manufacturing facilities located in Spain
- Certification details beyond cGMP not independently verified from public databases
- EU regulatory framework (EU Directive 2002/46/EC) differs from US 21 CFR Part 111
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between Euromed (Dermapharm) and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Our Evaluation Method
A full assessment applies six checks. Source-Checked listings get a lighter review.
- Independent confirmation: Claims backed by documentation, not marketing copy
- How recent the data is: Information reviewed and dated within the last 12 months
- Sources we traced: Sources cited for every key claim
- Inconsistencies flagged: Where a company's claims and public records disagree, we say so
- What we disclose: Material connections stated directly on affected listings
- What we don't know: When we can't assess something, we say so explicitly
Interested in Euromed (Dermapharm)?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.